Rising Global Healthcare Demand And US CDMO Will Boost Generic Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 21 Analysts
Published
20 Jun 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
₹6,528.02
18.1% undervalued intrinsic discount08 Aug
₹5,347.50
1Y
-6.8%7D
10.4%